Fresenius Medical Care AG FME
(Start of Section) | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Ertrag | 100,00% | 100,00% | 100,00% | 100,00% | 100,00% |
|---|
| Betriebskosten | 69,13% | 68,99% | 71,18% | 72,62% | 74,68% |
|---|
| Bruttogewinn | 30,87% | 31,01% | 28,82% | 27,38% | 25,32% |
|---|
| Vertriebsgemeinkosten | 17,51% | 17,72% | 17,57% | 19,51% | 16,43% |
|---|
| Forschung und Entwicklung | 0,96% | 1,09% | 1,25% | 1,18% | 1,19% |
|---|
| Umsatzrendite | 12,40% | 12,20% | 9,99% | 6,69% | 7,59% |
|---|
| Net Int, Inc and Other | 22,93% | 23,04% | 18,91% | 12,97% | 12,90% |
|---|
| EBIT Marge | 10,53% | 10,84% | 8,92% | 6,29% | 5,31% |
|---|
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Steuersatz | 2,30% | 2,80% | 2,00% | 1,68% | 1,54% |
|---|
| Nettomarge | 6,86% | 6,52% | 5,50% | 3,47% | 2,57% |
|---|
| Gesamtkapitalrendite | 4,05 | 3,60 | 2,93 | 1,92 | 1,43 |
|---|
| Financial Leverage | 2,75 | 2,83 | 2,71 | 2,56 | 2,49 |
|---|
| Eigenkapitalsrendite | 10,12 | 10,05 | 8,11 | 5,05 | 3,61 |
|---|